To recover your password please fill in your email address
Please fill in below form to create an account with us
Phase II gemcitabine and nab-paclitaxel for resectable pancreas cancer.
The effect of preoperative gemcitabine and nab-paclitaxel on the rate of surgery with complete removal of the tumour, compared with historical controls, in patients with resectable pancreas cancer.
Specialised Therapeutics, AGITG; NHMRC CTC
Adults 18 years and over with resectable pancreatic cancer
Australian Lead Group:
Andrew Barbour and David Goldstein